Chemoinformaics analysis of 3-Methylpentyl 2-methylprop-2-enoate
Molecular Weight | 170.252 | nRot | 5 |
Heavy Atom Molecular Weight | 152.108 | nRig | 2 |
Exact Molecular Weight | 170.131 | nRing | 0 |
Solubility: LogS | -3.319 | nHRing | 0 |
Solubility: LogP | 3.611 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 30.3063 |
nHD | 0 | BPOL | 20.6617 |
QED | 0.468 |
Synth | 2.766 |
Natural Product Likeliness | 1.009 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0 |
HIA | 0.002 |
CACO-2 | -4.322 |
MDCK | 0.000027 |
BBB | 0.475 |
PPB | 0.82693 |
VDSS | 0.972 |
FU | 0.227887 |
CYP1A2-inh | 0.957 |
CYP1A2-sub | 0.792 |
CYP2c19-inh | 0.716 |
CYP2c19-sub | 0.693 |
CYP2c9-inh | 0.703 |
CYP2c9-sub | 0.176 |
CYP2d6-inh | 0.109 |
CYP2d6-sub | 0.137 |
CYP3a4-inh | 0.065 |
CYP3a4-sub | 0.23 |
CL | 12.01 |
T12 | 0.511 |
hERG | 0.035 |
Ames | 0.007 |
ROA | 0.019 |
SkinSen | 0.929 |
Carcinogencity | 0.151 |
EI | 0.993 |
Respiratory | 0.607 |
NR-Aromatase | 0.055 |
Antiviral | No |
Prediction | 0.948017 |